Home > Boards > US Listed > Medical - Drugs > Cocrystal Pharma Inc. (COCP)

Im sure most here know that Dr. Schinazi

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
tredenwater2 Member Profile
 
Followed By 3
Posts 960
Boards Moderated 0
Alias Born 01/27/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 8:32:13 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/23/2019 6:01:32 AM
Cocrystal Pharma Commences Patient Enrollment for Hong Kong Phase 2a Study of CC-31244 for Ultra-Short Treatment of Hepatitis... GlobeNewswire Inc. - 5/20/2019 8:05:00 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 5/15/2019 8:37:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 8:01:26 AM
Cocrystal Pharma Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/10/2019 8:35:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:32:59 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/9/2019 5:15:08 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/30/2019 3:33:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 8:31:43 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/25/2019 8:33:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 4:27:45 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/15/2019 4:01:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2019 4:31:37 PM
Cocrystal Pharma Reports 2018 Financial Results and Provides Corporate Overview and Business Outlook GlobeNewswire Inc. - 4/1/2019 8:35:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 8:33:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2019 5:15:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2019 5:26:31 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 3/19/2019 5:02:35 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/19/2019 4:03:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/14/2019 8:47:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/11/2019 8:36:53 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 4:54:11 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/11/2019 5:32:51 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2019 4:18:17 PM
tredenwater2   Tuesday, 05/15/18 03:04:35 PM
Re: joe_techi post# 1206
Post # of 1221 
Im sure most here know that Dr. Schinazi was the inventor (or main player) in the last best in class Hep C drug that Gilead Sciences bought for approx 10 Billion.
Now he's owns a big chunk of this company next to Billionaire Dr. Frost and Teva which is creating another Best in Class Hep C drug. I doubt they are diddling around. Will history repeat itself and if so will it be Teva or Opko that pays up for the drug, or both?

Phase 2a.......may have to pick some up here soon.

Tred

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist